These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33198423)
1. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING). Xie X; Liu J; Wang X Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423 [TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists. Vavřina Z; Perlíková P; Milisavljević N; Chevrier F; Smola M; Smith J; Dejmek M; Havlíček V; Buděšínský M; Liboska R; Vaneková L; Brynda J; Boura E; Řezáčová P; Hocek M; Birkuš G J Med Chem; 2022 Oct; 65(20):14082-14103. PubMed ID: 36201304 [TBL] [Abstract][Full Text] [Related]
4. Crystal structures of porcine STING Cong X; Yuan Z; Du Y; Wu B; Lu D; Wu X; Zhang Y; Li F; Wei B; Li J; Wu J; Xu S; Wang J; Qi J; Shang G; Gu L J Biol Chem; 2019 Jul; 294(30):11420-11432. PubMed ID: 31167783 [TBL] [Abstract][Full Text] [Related]
5. Distinct Dynamic and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP. Guo J; Wang J; Fan J; Zhang Y; Dong W; Chen CP Chembiochem; 2019 Jul; 20(14):1838-1847. PubMed ID: 30895657 [TBL] [Abstract][Full Text] [Related]
6. The Chemistry of the Noncanonical Cyclic Dinucleotide 2'3'-cGAMP and Its Analogs. Schwede F; Genieser HG; Rentsch A Handb Exp Pharmacol; 2017; 238():359-384. PubMed ID: 27392950 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants. Wang Z; Zhao C; Wang C; Zhang H; Ma D; Zhang Q; Wen X; Li L; Xi Z Bioorg Med Chem; 2021 Jan; 29():115899. PubMed ID: 33285409 [TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route. Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802 [TBL] [Abstract][Full Text] [Related]
9. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis. Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508 [TBL] [Abstract][Full Text] [Related]
10. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice. Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601 [TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations provide structural insight into binding of cyclic dinucleotides to human STING protein. Aliakbar Tehrani Z; Rulíšek L; Černý J J Biomol Struct Dyn; 2022; 40(20):10250-10264. PubMed ID: 34187319 [TBL] [Abstract][Full Text] [Related]
12. Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions. Che X; Zhang J; Zhu Y; Yang L; Quan H; Gao YQ J Phys Chem B; 2016 Mar; 120(10):2670-80. PubMed ID: 26878265 [TBL] [Abstract][Full Text] [Related]
13. Detection of Cyclic Dinucleotides by STING. Du XX; Su XD Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286 [TBL] [Abstract][Full Text] [Related]
14. SLC19A1 Is an Importer of the Immunotransmitter cGAMP. Ritchie C; Cordova AF; Hess GT; Bassik MC; Li L Mol Cell; 2019 Jul; 75(2):372-381.e5. PubMed ID: 31126740 [TBL] [Abstract][Full Text] [Related]
15. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy. Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751 [TBL] [Abstract][Full Text] [Related]
16. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H. Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A Front Immunol; 2020; 11():238. PubMed ID: 32153571 [TBL] [Abstract][Full Text] [Related]
17. STING activation in cancer immunotherapy. Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799 [TBL] [Abstract][Full Text] [Related]
18. Replacement of oxygen with sulfur on the furanose ring of cyclic dinucleotides enhances the immunostimulatory effect Saito-Tarashima N; Kinoshita M; Igata Y; Kashiwabara Y; Minakawa N RSC Med Chem; 2021 Sep; 12(9):1519-1524. PubMed ID: 34671735 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789 [TBL] [Abstract][Full Text] [Related]
20. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy. Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]